Copyright Reports & Markets. All rights reserved.

Global Novel Drug Delivery Systems in Cancer Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Nanoparticles
      • 1.4.3 Liquid Embolics
      • 1.4.4 Embolization Particles
    • 1.5 Market by Application
      • 1.5.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2014-2025)
      • 1.5.2 Hospitals & Clinic
      • 1.5.3 Cancer Treatment Centers
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Novel Drug Delivery Systems in Cancer Therapy Market Size
    • 2.2 Novel Drug Delivery Systems in Cancer Therapy Growth Trends by Regions
      • 2.2.1 Novel Drug Delivery Systems in Cancer Therapy Market Size by Regions (2014-2025)
      • 2.2.2 Novel Drug Delivery Systems in Cancer Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Novel Drug Delivery Systems in Cancer Therapy Market Size by Manufacturers
      • 3.1.1 Global Novel Drug Delivery Systems in Cancer Therapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Novel Drug Delivery Systems in Cancer Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Novel Drug Delivery Systems in Cancer Therapy Key Players Head office and Area Served
    • 3.3 Key Players Novel Drug Delivery Systems in Cancer Therapy Product/Solution/Service
    • 3.4 Date of Enter into Novel Drug Delivery Systems in Cancer Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2014-2019)
    • 4.2 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Novel Drug Delivery Systems in Cancer Therapy Market Size (2014-2019)
    • 5.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in United States
    • 5.3 United States Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
    • 5.4 United States Novel Drug Delivery Systems in Cancer Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size (2014-2019)
    • 6.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Europe
    • 6.3 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
    • 6.4 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Application

    7 China

    • 7.1 China Novel Drug Delivery Systems in Cancer Therapy Market Size (2014-2019)
    • 7.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in China
    • 7.3 China Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
    • 7.4 China Novel Drug Delivery Systems in Cancer Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size (2014-2019)
    • 8.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Japan
    • 8.3 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
    • 8.4 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size (2014-2019)
    • 9.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
    • 9.4 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Application

    10 India

    • 10.1 India Novel Drug Delivery Systems in Cancer Therapy Market Size (2014-2019)
    • 10.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in India
    • 10.3 India Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
    • 10.4 India Novel Drug Delivery Systems in Cancer Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size (2014-2019)
    • 11.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Central & South America
    • 11.3 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Type
    • 11.4 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 Teva
      • 12.1.1 Teva Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
      • 12.1.4 Teva Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2014-2019)
      • 12.1.5 Teva Recent Development
    • 12.2 Johnson & Johnson
      • 12.2.1 Johnson & Johnson Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
      • 12.2.4 Johnson & Johnson Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2014-2019)
      • 12.2.5 Johnson & Johnson Recent Development
    • 12.3 Roche
      • 12.3.1 Roche Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
      • 12.3.4 Roche Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2014-2019)
      • 12.3.5 Roche Recent Development
    • 12.4 Takeda
      • 12.4.1 Takeda Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
      • 12.4.4 Takeda Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2014-2019)
      • 12.4.5 Takeda Recent Development
    • 12.5 AbbVie
      • 12.5.1 AbbVie Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
      • 12.5.4 AbbVie Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2014-2019)
      • 12.5.5 AbbVie Recent Development
    • 12.6 Samyang Biopharmaceuticals
      • 12.6.1 Samyang Biopharmaceuticals Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
      • 12.6.4 Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2014-2019)
      • 12.6.5 Samyang Biopharmaceuticals Recent Development
    • 12.7 Celgene
      • 12.7.1 Celgene Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
      • 12.7.4 Celgene Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2014-2019)
      • 12.7.5 Celgene Recent Development
    • 12.8 Spectrum Pharmaceuticals, Inc.
      • 12.8.1 Spectrum Pharmaceuticals, Inc. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
      • 12.8.4 Spectrum Pharmaceuticals, Inc. Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2014-2019)
      • 12.8.5 Spectrum Pharmaceuticals, Inc. Recent Development
    • 12.9 Gilead Sciences
      • 12.9.1 Gilead Sciences Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
      • 12.9.4 Gilead Sciences Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2014-2019)
      • 12.9.5 Gilead Sciences Recent Development
    • 12.10 Shire (Baxalta)
      • 12.10.1 Shire (Baxalta) Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Novel Drug Delivery Systems in Cancer Therapy Introduction
      • 12.10.4 Shire (Baxalta) Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2014-2019)
      • 12.10.5 Shire (Baxalta) Recent Development
    • 12.11 Merrimack

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
      Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
      In 2018, the global Novel Drug Delivery Systems in Cancer Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Novel Drug Delivery Systems in Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Novel Drug Delivery Systems in Cancer Therapy development in United States, Europe and China.

      The key players covered in this study
      Teva
      Johnson & Johnson
      Roche
      Takeda
      AbbVie
      Samyang Biopharmaceuticals
      Celgene
      Spectrum Pharmaceuticals, Inc.
      Gilead Sciences
      Shire (Baxalta)
      Merrimack

      Market segment by Type, the product can be split into
      Nanoparticles
      Liquid Embolics
      Embolization Particles

      Market segment by Application, split into
      Hospitals & Clinic
      Cancer Treatment Centers
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Novel Drug Delivery Systems in Cancer Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Novel Drug Delivery Systems in Cancer Therapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Novel Drug Delivery Systems in Cancer Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now